 |
|
|
| |
Reduced Changes in Bone Mineral Density in Chronic HBV Patients Receiving Tenofovir Alafenamide Compared With Tenofovir Disoproxil Fumarate
|
| |
| |
Reported by Jules Levin
APASL 2017 Feb 15-19 Shanghai, China
Wai-Kay Seto1, Yasuhiro Asahina2, Cheng-Yuan Peng3, Carol Stanciu4, Djamal Abdurakhmanov5, John F. Flaherty6, Kyungpil Kim6, Anuj Gaggar6, G Mani Subramanian6, Fehmi Tabak7, Tuan T. Nguyen8, Henry Lik-Yuen Chan9
1Queen Mary Hospital, Hong Kong; 2Tokyo Medical and Dental University, Tokyo, Japan; 3China Medical University Hospital, Taichung, Taiwan; 4University of Medicine and Pharmacy Gr. T. Popa, Iasi, Romania; 5Sechenov First Moscow State Medical University, Moscow, Russia; 6Gilead Sciences, Inc., Foster City, CA, USA; 7Istanbul Universitesi Cerrahpassa Tip Fakultesi Hastanesi, Istanbul, Turkey; 8Research and Education, Inc., San Diego, CA, USA; 9Prince of Wales Hospital, Hong Kong
|
| |
|
|
|
|
|
